Last $0.01 USD
Change Today -0.0045 / -25.71%
Volume 584.8K
OXIS On Other Exchanges
EN Paris
As of 8:10 PM 11/25/14 All times are local (Market data is delayed by at least 15 minutes).

oxis international inc (OXIS) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/11/14 - $0.03
52 Week Low
12/9/13 - $0.0030
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

oxis international inc (OXIS) Related Businessweek News

No Related Businessweek News Found

oxis international inc (OXIS) Details

Oxis International, Inc. researches, develops, and sells products that counteract the harmful effects of oxidative stress and inflammation. The company focuses on the development and sale/licensing of products and/or proprietary formulations, including functional foods and functional beverages; personal care products, including skin care and cosmetic products; veterinary products for companion animals, livestock, and performance animals, such as race horses; and proprietary compounds that might be out-licensed to biotechnology and/or pharmaceutical companies. It focuses on products that incorporate the amino acid naturally occurring compound, L-Ergothioneine, which is produced by microorganisms in soil and is not synthesized by humans, animals, or plants for use in combination with other nutraceuticals and botanicals in dietary supplements, functional foods and beverages, and topical anti-aging products. The company also discovers, develops, and commercializes novel therapeutics for various diseases. In addition, it owns one approved pharmaceutical product for veterinary use under the Palosein trademark. Oxis International, Inc. was founded in 1965 and is headquartered in Beverly Hills, California.

1 Employees
Last Reported Date: 11/18/14
Founded in 1965

oxis international inc (OXIS) Top Compensated Officers

Chairman of the Board and Chief Executive Off...
Total Annual Compensation: --
Compensation as of Fiscal Year 2012.

oxis international inc (OXIS) Key Developments

OXIS International Inc. Announces Board and Management Changes

OXIS International Inc. announced that on November 19, 2014, Kenneth Eaton resigned his positions as Chief Executive Officer and Board member to turn his attention to new opportunities. On the same day, the Board of Directors elected Anthony J. Cataldo as the company's new Chief Executive Officer, in which capacity he will serve concurrently with his position of Board Chairman. Anthony J. Cataldo, was first appointed to the Board of Directors on July 31, 2014. Before that, from February 2011 to June 2013, Mr. Cataldo served as Chairman and CEO/Founder of Genesis Biopharma Inc. Also the same day, Steven Weldon was elected President, in which position he will serve concurrently with his position as Chief Financial Officer. Steven Weldon was appointed to the Board of Directors in September, 2014 and as Chief Financial Officer in November, 2014. He has served on the board of several publicly traded companies as both, Chief Executive Officer and Chief Financial Officer.

OXIS International Inc. Appoints Steven Weldon as a Board of Directors, Chief Financial Officer and Chief Accounting Officer

OXIS International Inc. announced that on September 29, 2014, Steven Weldon was elected a member of the Board of Directors of the company and on November 3, 2014, was appointed the Chief Financial Officer and Chief Accounting Officer of the company. Mr. Weldon is a certified public accountant and is licensed to practice in the state of Florida. Mr. Weldon, has over 15 years of financial and accounting experience with public and private companies. Mr. Weldon was appointed as Chief Financial Officer and as a member of the board of directors of Growblox Sciences Inc., a Delaware corporation in September 2005 and serves in both positions currently. Mr. Weldon also served as chief executive officer of Growblox Sciences from December 29, 2009, through May 2, 2011, and from April 18, 2012, through March 13, 2014.

OXIS International Inc. Announces Board of Directors Changes

OXIS International Inc. announced effective as of July 25, 2014, Anshuman Dube and David Saloff resigned from their respective positions as members of the Board of Directors. Also effective as of July 25, 2014, Anthony Cataldo was appointed to the Board as a new director to fill one of the vacancies created by the aforementioned resignation of the two directors. Mr. Cataldo will serve as the Chairman of the Board of Directors. Mr. Cataldo previously served as a director and as the company’s Chief Executive Officer from March 2009 to August 2011.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OXIS:US $0.01 USD -0.0045

OXIS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for OXIS.
View Industry Companies

Industry Analysis


Industry Average

Valuation OXIS Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OXIS INTERNATIONAL INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at